Pharmaceutical - Financial, Hematology

Filter

Current filters:

FinancialHematology

Popular Filters

Australia’s CSL posts solid half-year results

Australia’s CSL posts solid half-year results

13-02-2014

Australian blood products and vaccine maker CSL reported a 3% rise in net profit to $646 million (all…

CSL LimitedFinancialHematologyPharmaceuticalVaccines

$20 million milestones for MacroGenics from Servier

$20 million milestones for MacroGenics from Servier

06-02-2014

Servier, France’s largest privately‐held pharmaceutical company, has exercised its exclusive option…

FinancialHematologyLicensingMacroGenicsMGD006OncologyPharmaceuticalServier

New Zealand to fully subsidize Abbott Lab’s Ferrograd

New Zealand to fully subsidize Abbott Lab’s Ferrograd

06-01-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has approved an agreement with the local subsidiary…

Abbott LaboratoriesAsia-PacificFerrogradFinancialHematologyPharmaceutical

Kyiv Investment Group to spend $50 million in Russian blood preparations and recombinant drugs production

29-11-2013

Kyiv Investment Group, one of Ukraine’s largest investment groups, has announced its plans to invest…

Biotest AGEastern EuropeFinancialHematologyKyiv InvestmentMicrogenPharmaceuticalProduction

Acquisition costs take toll on Baxter’s 3rd-qtr financials

18-10-2013

USA-based Baxter International has posted solid financial results for the third quarter of 2013, showing…

Baxter InternationalFinancialHematologyPharmaceutical

CSL settles US antitrust class action litigation

CSL settles US antitrust class action litigation

09-10-2013

Australian blood products and vaccine maker CSL has signed an agreement to settle the US antitrust class…

CSL LimitedFinancialHematologyLegalNorth AmericaPharmaceutical

Back to top